FMP
Pasithea Therapeutics Corp.
KTTA
NASDAQ
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
7.13 USD
0.08 (1.12%)
About
ceo
Dr. Tiago Reis Marques M.D., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.pasithea.com
exchange
NASDAQ
Description
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
CIK
0001841330
ISIN
US70261F2020
CUSIP
70261F103
Address
1111 Lincoln Road
Phone
702 514 4174
Country
US
Employee
8
IPO Date
Sep 15, 2021
Key Executives
